Viewing Study NCT03715166

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:32 PM

Ignite Modification Date: 2026-01-07 @ 3:08 PM

Study NCT ID: NCT03715166

Status: TERMINATED

Last Update Posted: 2024-07-25

First Post: 2018-10-12

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder

Sponsor: Institut de Recherches Internationales Servier

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module